Health
New study charts the complexity of SARS-CoV-2 neutralization – EurekAlert
In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains…
Washington, DC – February 24, 2021 – In the absence of effective treatments for COVID-19, many countries have approved the therapeutic use of blood plasma from recovering patients because it contains antibodies against the coronavirus. But not every type of antibody can neutralize the virus and render it noninfectious. New research published this week in mSphere, an open-access journal of the American Society for Microbiology, explores variation in virus neutralization capabilities, which can vary…
-
General18 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General23 hours agoRescuers pull children from the rubble of Indonesian boarding school collapse
-
Business22 hours agoDoes Macquarie rate Karoon Energy shares a buy, hold or sell?
-
Noosa News23 hours agoThree steps Queensland SES want you to know to Get Ready for severe weather